Publications by authors named "Patrick Garibay"

Claim this Profile
D
Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog.
Kristian Sass-Ørum, Tina Møller Tagmose, Jørgen Olsen, Annika Sjölander, Per-Olof Wahlund, Patrick Garibay

J Med Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320.
Thomas B Kjeldsen, František Hubálek, Tina M Tagmose, Lone Pridal, Hanne H F Refsgaard, Patrick W Garibay

J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Molecular engineering of safe and efficacious oral basal insulin.
Frantisek Hubálek, Hanne H F Refsgaard, Sanne Gram-Nielsen, Peter Madsen, Erica Nishimura, Patrick W Garibay

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular engineering of safe and efficacious oral basal insulin.
Frantisek Hubálek, Hanne H F Refsgaard, Sanne Gram-Nielsen, Peter Madsen, Erica Nishimura, Patrick W Garibay

Nat Commun· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.
Christina Rye Underwood, Lotte Bjerre Knudsen, Patrick W Garibay, Günther H Peters, Steffen Reedtz-Runge

Peptides· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
Christina Rye Underwood, Patrick Garibay, Lotte Bjerre Knudsen, Sven Hastrup, Günther H Peters

J Biol Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis